Shares of Diploma PLC (LON:DPLM – Get Rating) have been assigned a consensus recommendation of “Hold” from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is GBX 2,944.29 ($36.62).
A number of equities research analysts recently issued reports on DPLM shares. Jefferies Financial Group restated a “hold” rating and issued a GBX 2,600 ($32.34) target price on shares of Diploma in a report on Friday, March 17th. Berenberg Bank restated a “buy” rating and issued a GBX 3,360 ($41.79) target price on shares of Diploma in a report on Tuesday, May 16th. Barclays restated an “overweight” rating and issued a GBX 3,400 ($42.29) target price on shares of Diploma in a report on Tuesday, May 16th. JPMorgan Chase & Co. restated an “underweight” rating and issued a GBX 2,400 ($29.85) target price on shares of Diploma in a report on Tuesday, May 16th. Finally, Shore Capital restated a “buy” rating on shares of Diploma in a report on Monday, May 15th.
Diploma Stock Performance
Shares of LON DPLM opened at GBX 2,944 ($36.62) on Wednesday. The company has a market cap of £3.95 billion, a PE ratio of 3,873.68, a price-to-earnings-growth ratio of 2.82 and a beta of 0.69. Diploma has a 12 month low of GBX 2,090 ($26.00) and a 12 month high of GBX 3,116 ($38.76). The company has a debt-to-equity ratio of 33.34, a current ratio of 1.87 and a quick ratio of 0.80. The company has a 50-day simple moving average of GBX 2,738.51 and a 200-day simple moving average of GBX 2,785.66.
Diploma Cuts Dividend
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.